Advancing Health Data with AI Analytics
Samsung and Verily Partner for Clinical Research AI
New collaboration integrates Galaxy Watch data into Verily's health platform for clinical trials at HIMSS 2026.
A close-up of a Galaxy Watch on a wrist displaying health metrics, with a soft-focus medical research background representing the Samsung and Verily clinical partnership.
Photo: Avantgarde News
Samsung and Verily announced a partnership at HIMSS 2026 to improve clinical research using wearable technology [1][2]. The collaboration integrates Galaxy Watch data with Verily’s health platform to support pharmaceutical and government sponsors [2][3]. The initiative uses artificial intelligence to analyze real-world evidence and identify digital biomarkers [1][3]. These companies aim to make clinical trials more efficient and accessible for participants worldwide [2].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
fiercehealthcare.com
https://www.fiercehealthcare.com/health-tech/driving-news-himss26-verily-samsung-ink-collaboration-meditechs-latest-ai-solutions
- 2.↗
businesswire.com
https://www.businesswire.com/news/home/20260309932457/en/Verily-and-Samsung-Collaborate-to-Accelerate-Clinical-Research-with-the-Galaxy-Watch-and-Pre-Platform
- 3.↗
medcitynews.com
https://medcitynews.com/2026/03/verily-samsung-wearable-smartwatch-healthcare-pharma-research/
Related stories
View all
Topics
About the author
Avantgarde News Desk covers advancing health data with ai analytics and editorial analysis for Avantgarde News.